Publication:
Role of APOBEC3H in the Viral Control of HIV Elite Controller Patients.

dc.contributor.authorBenito, José Miguel
dc.contributor.authorHillung, Julia
dc.contributor.authorRestrepo, Clara
dc.contributor.authorCuevas, José M
dc.contributor.authorLeón, Agathe
dc.contributor.authorRuiz-Mateos, Ezequiel
dc.contributor.authorPalacios-Muñoz, Rosario
dc.contributor.authorSanjuán, Rafael
dc.date.accessioned2024-02-08T14:40:57Z
dc.date.available2024-02-08T14:40:57Z
dc.date.issued2018-01-01
dc.description.abstractBackground: APOBEC3H (A3H) gene presents variation at 2 positions (rs139297 and rs79323350) leading to a non-functional protein. So far, there is no information on the role played by A3H in spontaneous control of HIV. The aim of this study was to evaluate the A3H polymorphisms distribution in a well-characterized group of Elite Controller (EC) subjects. Methods: We analyzed the genotype distribution of two different SNPs (rs139297 and rs79323350) of A3H in 30 EC patients and compared with 11 non-controller (NC) HIV patients. Genotyping was performed by PCR, cloning and Sanger sequencing. Both polymorphisms were analyzed jointly in order to adequately attribute the active or inactive status of A3H protein. Results: EC subjects included in this study were able to maintain a long-term sustained spontaneous HIV-viral control and optimal CD4-T-cell counts; however, haplotypes leading to an active protein were very poorly represented in these patients. We found that the majority of EC subjects (23/30; 77%) presented allelic combinations leading to an inactive A3H protein, a frequency slightly lower than that observed for NC studied patients (10/11; 91%). Conclusions: The high prevalence of non-functional protein coding-genotypes in EC subjects seems to indicate that other innate restriction factors different from APOBEC3H could be implicated in the replication control exhibited by these subjects.
dc.format.number2es_ES
dc.format.page95-100es_ES
dc.format.volume15es_ES
dc.identifier.doi10.7150/ijms.22317
dc.identifier.e-issn1449-1907es_ES
dc.identifier.journalInternational journal of medical scienceses_ES
dc.identifier.otherhttp://hdl.handle.net/10668/12011
dc.identifier.pubmedID29333092es_ES
dc.identifier.urihttp://hdl.handle.net/20.500.12105/17569
dc.language.isoeng
dc.rights.accessRightsopen accesses_ES
dc.rights.licenseAttribution-NonCommercial 4.0 International*
dc.rights.urihttp://creativecommons.org/licenses/by-nc/4.0/*
dc.subjectAPOBEC3H polymorphisms
dc.subjectHIV
dc.subjectElite controllers
dc.subjectrs139297
dc.subjectrs79323350
dc.subject.meshAdult
dc.subject.meshAminohydrolases
dc.subject.meshCD4-Positive T-Lymphocytes
dc.subject.meshCross-Sectional Studies
dc.subject.meshFemale
dc.subject.meshGene Frequency
dc.subject.meshHIV Infections
dc.subject.meshHaplotypes
dc.subject.meshHumans
dc.subject.meshMale
dc.subject.meshMiddle Aged
dc.subject.meshPolymorphism, Single Nucleotide
dc.subject.meshVirus Replication
dc.titleRole of APOBEC3H in the Viral Control of HIV Elite Controller Patients.
dc.typeresearch article
dc.type.hasVersionVoR
dspace.entity.typePublication

Files